Optic Atrophy clinical trials
The registry lists 21 studies for Optic Atrophy across more than 10 countries. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-23.
Status
- Completed
- 10
- Recruiting
- 5
- Status unknown
- 4
- Active, not recruiting
- 1
- Terminated
- 1
Phase
- Phase 2
- 5
- Phase 1
- 5
- Phase 3
- 2
Where
- United States
- 9
- France
- 3
- Israel
- 2
- Italy
- 2
- Australia
- 2
- Netherlands
- 2
Who runs them
Washington University School of Medicine (3) · State University of New York at Buffalo (2) · Glostrup University Hospital, Copenhagen (1) · PYC Therapeutics (1) · The Foundation for Orthopaedics and Regenerative Medicine (1) · Quark Pharmaceuticals (1) · Okuvision GmbH (1) · Sanford Health (1)
Studies
Recruiting first, then most recently updated. Showing 21 of 21 — search for more.
- Stem Cell Ophthalmology Treatment Study IIRecruitingNCT03011541Not applicable3 countries
- Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical StudyRecruitingNCT028415531 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAIONRecruitingNCT05147701Phase 12 countries
- Phenotypes, Biomarkers and Pathophysiology in Spastic AtaxiasRecruitingNCT042978917 countries
- I-Tracking Neurodegeneration in Early Wolfram SyndromeCompletedNCT039512981 country
- Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)Active, not recruitingNCT05733572Phase 21 country
- Building Research With Artificial Intelligence in Neuro-OphthalmologyCompletedNCT063905791 country
- Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 MutationTerminatedNCT061403296 countries
- A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram SyndromeCompletedNCT02829268Phase 1/21 country
- Natural History Study of FDXR Mutation-related MitochondriopathyCompletedNCT045809791 country
- Natural History Study of SLC25A46 Mutation-related MitochondriopathyCompletedNCT045945901 country
- Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographCompletedNCT047231601 country
- Systemic Erythropoietin Injection in Patients Having Optic AtrophyCompletedNCT04680143Phase 1/21 country
- Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based TherapyStatus unknownNCT02882477Phase 2/31 country
- Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve DiseaseStatus unknownNCT01834079Phase 1/21 country
- Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION PatientsCompletedNCT01064505Phase 12 countries
- A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)CompletedNCT00528151Phase 31 country
- Transcorneal Electrical Stimulation Therapy for Retinal DiseaseCompletedNCT00804102Not applicable
- Advanced Characterization of Autosomal Dominant Optic AtrophyStatus unknownNCT015226381 country
- Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung AdenocarcinomaStatus unknownNCT012490531 country